Thyroid hormones and energy in graves' or thyroid cancer
Part of Cancer, Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial studies how thyroid hormone levels affect your body's use of sugar and energy. It may help people newly diagnosed with Graves' disease or thyroid cancer understand their metabolism better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with Graves' disease.
- Or you have been newly diagnosed with thyroid cancer.
- You do not have diabetes or very high blood sugar.
- You are not taking insulin that works during the test.
- You do not have a current infection or serious illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
This study observes people with various thyroid conditions, including overactive or underactive thyroid, to learn more about how these disorders develop and progress over time. It may help improve future diagnosis and treatment.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
This study compares different treatment plans to see how well they control Graves’ disease and whether it comes back. It may help by identifying which approach works best to prevent relapse.
This trial uses a special ultrasound to look at blood flow in the thyroid gland, which may help monitor how well treatment for Graves' disease is working in children. It is for children who are newly diagnosed with an overactive thyroid.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.